Influential Hydroxychloroquine Study Retracted – Clinical Trials Resume


This is my 4th article on Hydroxychloroquine – why am I so fixated you may ask – my response to that is that my gut instinct tells me this is a major story, one which is not being covered by the mainstream media for a reason.

I draw your attention to my previous article entitled “World Health Organisation halts clinical trial of Covid-19 treatment – but only for hydroxychloroquine.  



In that article it states:- the World Health Organisation Chief Tedros Adhanom Ghebreyesus told a virtual press conference that they had temporarily suspended clinical trials of hydroxychloroquine as a result of a study published in The Lancet medical journal which suggested the drug could increase the risk of death among Covid-19 patients.  All other arms of the clinical trial will continue.”




I questioned why the Lancet had only produced a paper on Hydroxychloroquine” and not the other 3 treatments within the clinical trial – A very pertinent question to ask it would appear. 


You could have knocked me down with a feather when I stumbled across new information which corroborates my initial concern based upon “gut instinct”.  

The article was entitled……

“Authors retract influential study linking Hydroxychloroquine to mortality risk for coronavirus patients”

Three authors have RETRACTED an influential study on the risks of hydroxychloroquine as a treatment for COVID-19.  The three authors, Dr. Mandeep Mehra, medical director of the Brigham Heart and Vascular Center, Dr. Amit Patel, director of clinical regenerative medicine and tissue engineering at the University of Utah, and Dr. Frank Ruschitzka, chairman of the cardiology department at University Hospital Zurich.  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext

The Lancet study prompted the World Health Organization to cease its trial of the drug and France to ban its use. Dr Anthony Fauci, one of the lead members of the Trump administration’s coronavirus task force, declared hydroxychloroquine to be ineffective in treating COVID-19.

The “study” had found that hydroxychloroquine, an anti-malaria drug, increased mortality and heart problems in patients suffering from coronavirus.  It had been cited in criticizing President Trump’s promotion of the drug as a remedy for the disease.


But questions arose about how one of the authors, Dr. Sapan Desai, and the company he owns, Surgisphere, were able to compile a massive dataset with very few employees and in a short amount of time.

The authors are retracting the article, as they “can no longer vouch for the veracity of the primary data sources” because Surgisphere would not provide the dataset for an independent review.  

It has now been learned that the company that did the study is a front company of some kind.  Surgisphere was founded in 2008 by Sapan Desai, who is also the co-author of the Lancet study.  


Desai claims Surgisphere has 11 employees. The company’s marketing executive appears to be a pornographic model and event hostess, while its science editor appears to be a science fiction author.


There’s no evidence online of Surgisphere having any analytical software earlier than a year ago. 

Desai’s Wikipedia page has now been deleted following questions about Surgisphere and his history, first raised in 2010.

Peter Ellis, the chief data scientist of Nous Group, an international management consultancy that does data integration projects for government departments, told the Guardian that Surgisphere “was almost certainly a scam”.  

The Guardian reports


The World Health Organisation and a number of national governments have changed their Covid-19 policies and treatments on the basis of flawed data from a little-known US healthcare analytics company, also calling into question the integrity of key studies published in some of the world’s most prestigious medical journals.


The journal has now issued an “expression of concern,” and wants an apology from the company.


On Wednesday 3rd June, the WHO announced the trials would now resume.




I have been following the use of Hydroxychloroquine, Azithromycin + Zinc ever since the Trump “game changer” announcement was made during a Press Conference in early 2020.  


There have been major successes documented within the medical community of Hydroxychloroquine when used to treat Covid-19 patients, indeed President Trump has himself taken the drug as a preventative measure on the advice of trusted front line medical staff.


Q1: How did this paper get published in such a renowned medical journal without checking the validity of its data; and 

Q2. Why were the World Health Organisation so quick to stop the trial of Hydroxychloroquine off the back of it?

A Full Public Inquiry 

I believe a full public inquiry is necessary and if it is found that any party involved in the clinical trials has tampered or meddled with the results in any way to change the outcome for either political or financial gain they have to be exposed.


Also if any party within the medical/pharmaceutical or vaccine community is found to have suppressed information or withheld personal knowledge of a potential remedy for Covid-19 patients in order to profiteer they MUST BE BROUGHT TO JUSTICE and feel the full force of the law.

More to follow…..







Leave a Reply